Orbimed Advisors - STRONGBRIDGE BIOPHARMA PLC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$1,621,000
-68.7%
794,675
-54.5%
0.02%
-65.4%
Q2 2021$5,182,000
+7.6%
1,744,6690.0%0.05%
+15.6%
Q1 2021$4,815,000
-43.2%
1,744,669
-50.0%
0.04%
-39.2%
Q4 2020$8,479,000
+15.7%
3,489,3690.0%0.07%
-19.6%
Q3 2020$7,328,0003,489,3690.09%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$13,819,00013.33%
Prosight Management, LP 1,258,224$2,630,0001.16%
Stonepine Capital Management, LLC 431,853$903,0000.63%
NEA Management Company, LLC 4,141,308$8,665,0000.41%
Alambic Investment Management, L.P. 118,364$247,0000.21%
683 Capital Management, LLC 608,971$1,273,0000.15%
PA Capital LLC 77,799$163,0000.14%
Hudson Bay Capital Management LP 2,075,000$4,337,0000.10%
KNOTT DAVID M 100,000$209,0000.08%
Aristides Capital LLC 35,517$74,0000.06%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders